InvestorsHub Logo
Followers 0
Posts 2177
Boards Moderated 0
Alias Born 04/13/2018

Re: misiu143 post# 159380

Friday, 04/16/2021 7:15:37 PM

Friday, April 16, 2021 7:15:37 PM

Post# of 232963
So here is what happens with an approval. Any company HGEN, CYDY, Billy Bob Biotech LTD, they will immediately get into production. They will start producing what they can. At the same time, they can also start taking sales orders. That's the big one.

But let's dive back into production for a minute because people don't realize what happens when other expected drugs fail, demand for a new drug rises and how these manufacturing facilities shift to meet the burden of demand.

These manufacturing facilities will allocate more people and equipment to production if need be. If Remedesivir was the standard of care but another drug overtakes it or is more critically needed the demands of the market will dictate that Gilead reduce the amount of Remedesvir being produced opening up more space. The hot new drug on the market will naturally continue to expand in production.

Let's look at Velkury, AKA Remedesivir, and it's production timeline. It's not a simple drug and takes weeks to produce.

https://www.gilead.com/purpose/advancing-global-health/covid-19/working-to-supply-veklury-for-covid-19

So yeah coming up with 100,000 doses isn't a mission to the moon. Odds are if HGEN gets an EUA someone may actually buy them up. Gilead has a market lead to protect, and J&J just saw their vaccine stall out. Two solid candidates that could and would take a COVID drug with solid topline results. Topline results dervided from using all the patients in the study to get numbers.

Nader not understanding that drugs can be mass produced, or the attractiveness of a COVID drug with an EUA shows you what a simpleton he is a best, what a terrible liar he is at the worst.

Don't Blink.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News